Alimera Sciences Analyst Ratings
Alimera Sciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 51.98% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 06/12/2023 | 143.16% | Alliance Global Partners | $4.5 → $8 | Upgrades | Neutral → Buy |
| 05/25/2023 | 51.98% | HC Wainwright & Co. | → $5 | Reiterates | Buy → Buy |
| 05/19/2023 | 51.98% | HC Wainwright & Co. | $9 → $5 | Maintains | Buy |
| 05/16/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/03/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 02/23/2023 | 173.56% | HC Wainwright & Co. | → $9 | Reiterates | → Buy |
| 11/21/2022 | 36.78% | Alliance Global Partners | $11 → $4.5 | Downgrades | Buy → Neutral |
| 07/28/2022 | 173.56% | HC Wainwright & Co. | $8 → $9 | Maintains | Buy |
| 05/10/2022 | 143.16% | HC Wainwright & Co. | $10 → $8 | Maintains | Buy |
| 02/25/2022 | 203.95% | HC Wainwright & Co. | $12 → $10 | Maintains | Buy |
| 08/16/2021 | 264.74% | HC Wainwright & Co. | $16 → $12 | Maintains | Buy |
| 04/15/2021 | 386.32% | HC Wainwright & Co. | $14 → $16 | Maintains | Buy |
| 04/14/2020 | 325.53% | HC Wainwright & Co. | $15 → $14 | Reiterates | → Buy |
| 04/07/2020 | 355.93% | B. Riley Securities | $24 → $15 | Maintains | Buy |
| 11/18/2019 | 355.93% | HC Wainwright & Co. | $1 → $15 | Maintains | Buy |
| 10/31/2019 | -69.6% | HC Wainwright & Co. | $1.5 → $1 | Maintains | Buy |
| 05/28/2019 | -8.81% | Craig-Hallum | → $3 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 51.98% | HC Wainwright公司 | →$5 | 重申 | 購買→購買 |
| 2023/06/12 | 143.16% | 聯盟全球合作夥伴 | $4.5→$8 | 升級 | 中性→購買 |
| 2023年05月25日 | 51.98% | HC Wainwright公司 | →$5 | 重申 | 購買→購買 |
| 2023年05月19日 | 51.98% | HC Wainwright公司 | $9→$5 | 維護 | 買 |
| 2023年05月16日 | 173.56% | HC Wainwright公司 | →$9 | 重申 | 購買→購買 |
| 04/03/2023 | 173.56% | HC Wainwright公司 | →$9 | 重申 | →購買 |
| 02/23/2023 | 173.56% | HC Wainwright公司 | →$9 | 重申 | →購買 |
| 2022年11月21日 | 36.78% | 聯盟全球合作夥伴 | $11→$4.5 | 評級下調 | 購買→中性 |
| 07/28/2022 | 173.56% | HC Wainwright公司 | $8→$9 | 維護 | 買 |
| 2022年05月10日 | 143.16% | HC Wainwright公司 | $10→$8 | 維護 | 買 |
| 02/25/2022 | 203.95% | HC Wainwright公司 | $12→$10 | 維護 | 買 |
| 08/16/2021 | 264.74% | HC Wainwright公司 | $16→$12 | 維護 | 買 |
| 04/15/2021 | 386.32% | HC Wainwright公司 | $14→$16 | 維護 | 買 |
| 04/14/2020 | 325.53% | HC Wainwright公司 | $15→$14 | 重申 | →購買 |
| 04/07/2020 | 355.93% | B.萊利證券 | $24→$15 | 維護 | 買 |
| 2019年11月18日 | 355.93% | HC Wainwright公司 | $1→$15 | 維護 | 買 |
| 2019年10月31日 | -69.6% | HC Wainwright公司 | $1.5→$1 | 維護 | 買 |
| 2019年05月28日 | -8.81% | 克雷格-哈勒姆 | →$3 | 開始承保 | →購買 |
What is the target price for Alimera Sciences (ALIM)?
阿裡梅拉科學公司(Alim)的目標價是多少？
The latest price target for Alimera Sciences (NASDAQ: ALIM) was reported by HC Wainwright & Co. on August 14, 2023. The analyst firm set a price target for $5.00 expecting ALIM to rise to within 12 months (a possible 51.98% upside). 8 analyst firms have reported ratings in the last year.
2023年8月14日，HC Wainwright&Co.報道了阿裡梅拉科學公司(納斯達克代碼：ALIM)的最新目標價。這家分析公司將目標價定為5.00美元，預計Alim將在12個月內上漲(可能上漲51.98%)。去年有8家分析公司公佈了評級。
What is the most recent analyst rating for Alimera Sciences (ALIM)?
Alimera Sciences(Alim)的最新分析師評級是什麼？
The latest analyst rating for Alimera Sciences (NASDAQ: ALIM) was provided by HC Wainwright & Co., and Alimera Sciences reiterated their buy rating.
分析師對阿裡梅拉科學公司(納斯達克代碼：ALIM)的最新評級由HC Wainwright&Co.提供，阿裡梅拉科學公司重申其買入評級。
When is the next analyst rating going to be posted or updated for Alimera Sciences (ALIM)?
Alimera Sciences(Alim)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alimera Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alimera Sciences was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Alimera Sciences的高管和客戶交談，以及收聽收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Alimera Sciences的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating Alimera Sciences (ALIM) correct?
分析師對Alimera Sciences(Alim)的評級正確嗎？
While ratings are subjective and will change, the latest Alimera Sciences (ALIM) rating was a reiterated with a price target of $0.00 to $5.00. The current price Alimera Sciences (ALIM) is trading at is $3.29, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Alimera Sciences(Alim)評級被重申，目標價在0.00美元至5.00美元之間。Alimera Sciences(Alim)目前的交易價格為3.29美元，在分析師的預測範圍內。